Rising R&D investment by pharmaceutical and biotechnology companies is expected to push the clinical trial supplies market to $8.95b by 2031.
It is forecast to reach $8.95b. The clinical trial supplies market is projected to reach $8.95b by 2031, driven by pharmaceutical and biotechnology research and development (R&D) spending. According to MarketsandMarkets, the rising number of clinical trials and wider use of decentralised and adaptive study designs are also driving market growth. The services segment is sub-segmented into logistics
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →